QLT Inc : * Announces oral retinoid program clinical and regulatory update, and review of strategic alternatives * Says for the review, the board of directors has engaged Credit Suisse to act
QLT Inc., is a biotechnology company. The Company is engaged in the development and commercialization of ocular products. Shares of QLT traded higher by 12.16% or $0.59/share to $5.44. In the past year, the shares have traded as low as $3.83 and as high as $9.20. On average, 3194 shares of QLT.TO exchange hands on a given day and today's volume is recorded at 30897.
QLT Inc., is a biotechnology company. The Company is engaged in the development and commercialization of ocular products. Shares of QLTI traded higher by 11.88% or $0.55/share to $5.18. In the past year, the shares have traded as low as $3.69 and as high as $9.10. On average, 85977 shares of QLTI exchange hands on a given day and today's volume is recorded at 818287.
Source
